pentobarbital will reduce the extent or impact of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Use of different treatment plans is strongly advisable when linagliptin is always to be administered which has a CYP3A4 inducerpentobarbital will lessen the level or result of dasatinib by affecting hepatic/in